Clinical Outcomes From Nalmefene

Clinical trial NCT05808881 · WITHDRAWN

Trial details

NCT number: NCT05808881
Sponsor: Purdue Pharma LP
Status: WITHDRAWN
Phase: Phase 4
Study type: INTERVENTIONAL

Opioid Overdose

Start date: 2023-06-01
Primary completion: 2024-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.